April 2021

Preventive Care and the Patient Voice on the Road to Value-Based Care

04/22/2021

Winston Wong, PharmD

Chronic diseases are a tremendous burden to both patients and the health care system. Preventive strategies are available for many chronic diseases; these strategies include reducing risk factors, detecting and...

...

04/22/2021

Journal of Clinical Pathways

Integrating Artificial Intelligence and ePROs Into Clinical Workflows

04/22/2021

The cost of health care in America has grown at a startling rate in the past several decades. According to a 2019 survey of highly developed countries by the Organisation for Economic Co-operation and Development...

The...

04/22/2021

Journal of Clinical Pathways

News

Conference Coverage

Society of Gynecologic Oncology 2021 Annual Meeting on Women’s Cancer

04/22/2021

JCP Editors

Real-World Tolerability of PARP Inhibitors for Ovarian Cancer in the United States A study presented at the virtual 2021 Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer compared the...

...

04/22/2021

Journal of Clinical Pathways

Department

Research in Review

04/22/2021

JCP Editors

Digital Care Delivery Models and Staffing Concerns Amidst the COVID-19 Pandemic A panel at the virtual ACCC 47th Annual Meeting & Cancer Center Business Summit shared real-world experiences on the impact of the...

...

04/22/2021

Journal of Clinical Pathways

Column

Clinical Pathways GPS

Virtual Health Care: Advances, Coverage, and Use

04/22/2021

Empowered consumers, increasingly interoperable data, and scientific and technological advances are transforming the health care system we know today. Virtual health has the capacity to inform, personalize,...

...

04/22/2021

Journal of Clinical Pathways

Pharma Insights

Bending the Health Care Cost Curve and Changing the Drug Cost Paradigm in 2021 and Beyond

04/22/2021

Elizabeth Oyekan, PharmD, FCSHP, CPHQ

Andrew Cournoyer, RPh, MBA

The continued rise in health care spending continues to have a profound effect on the US economy and health care payers. The three complex drivers contributing to these increases include hospital, outpatient, and...

The...

04/22/2021

Journal of Clinical Pathways

Feature

Research Reports

Pediatric Sunscreen Coverage by Medicaid as a Primary Prevention Strategy to Reduce Melanoma Burden: A Cost-Effectiveness Analysis

04/22/2021

Dawn Queen, MD

Christine Lauren, MD

Richard D Carvajal, MD

Megan H Trager, MD

Connor Stonesifer, BA

Chin Hur, MD, MPH

Robert Stern, MD

Daniel C Malone, RPh, PhD, FAMCP

Larisa J Geskin, MD

Abstract: Melanoma treatment costs continue to rise. Sunscreen is a photoprotective tool that may reduce the incidence of melanoma but can be cost prohibitive for lower socioeconomic populations. New York State...

...

04/22/2021

Journal of Clinical Pathways

Perspectives

Patient Voices in Value-Based Cancer Care: Priorities for the Biden Administration

04/22/2021

Theresa Schmidt, MA

Jacqlyn Riposo, MBA

Tom Valuck, MD, JD

Kimberly Westrich, MA

Ethan Basch, MD, MSc

Mark McClellan, MD, PhD

Abstract: The Biden administration has an opportunity to prioritize patient perspectives in innovative value-based payment models for oncology by incorporating meaningful patient-reported measures (PRMs) and...

...

04/22/2021

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

April 2021

News

Department

Column

Feature

Current Issue

Special Reports

Subscribe

Volume 7

Specialties

Events

Year Round Education

HMP Global Products